Applicability of adipose-derived mesenchymal stem cells in treatment of patients with type 2 diabetes
Abstract Type 2 diabetes mellitus (T2DM) is mainly characterized by insulin resistance (IR) and impaired insulin secretion. The chronic inflammatory process contributed to IR and could also hamper pancreatic β cell function. However, currently applied treatment cannot reverse β cell damage or allevi...
Main Authors: | Yicheng Qi, Jing Ma, Shengxian Li, Wei Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2019-08-01
|
Series: | Stem Cell Research & Therapy |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13287-019-1362-2 |
Similar Items
-
Mesenchymal stem cell-derived exosomes for the treatment of pulmonary diseases
by: X. Wang, et al.
Published: (2020-10-01) -
Mesenchymal Stromal Cells
by: Stanisław Szala, et al.
Published: (2014-11-01) -
Adipose-derived mesenchymal stem cells from obese mice prevent body weight gain and hyperglycemia
by: Yicheng Qi, et al.
Published: (2021-05-01) -
Freeze-Dried Secretome (Lyosecretome) from Mesenchymal Stem/Stromal Cells Promotes the Osteoinductive and Osteoconductive Properties of Titanium Cages
by: Elia Bari, et al.
Published: (2021-08-01) -
Adipose-Derived Mesenchymal Stem Cells (AD-MSCs) against Ultraviolet (UV) Radiation Effects and the Skin Photoaging
by: Pietro Gentile, et al.
Published: (2021-05-01)